Literature DB >> 2767048

The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon.

N J Webster1, S Green, D Tasset, M Ponglikitmongkol, P Chambon.   

Abstract

Using GAL4 chimeric receptors, we have reported previously that the hormone-binding domain (HBD) of the human oestrogen receptor (hER) contains an hormone-inducible transcription activation function. We have extended that study here to show that this activation function represents the major activating domain in the hER in HeLa cells. In addition, we have expressed the various exons encoding the hER HBD as GAL4 fusion proteins and have shown that none contain a discrete activation function. Thus the activating domain of the hER HBD appears to be different from the recently characterized 'simple' activating domains, such as acidic 'blob' or amphipathic helix, and more likely corresponds to a protein surface created from dispersed elements and dependent upon the three-dimensional folding of the HBD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767048      PMCID: PMC400972          DOI: 10.1002/j.1460-2075.1989.tb03526.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

Review 1.  A human retinoic acid receptor which belongs to the family of nuclear receptors.

Authors:  M Petkovich; N J Brand; A Krust; P Chambon
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

2.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A.

Authors:  S Green; P Walter; V Kumar; A Krust; J M Bornert; P Argos; P Chambon
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

Review 3.  Steroid receptor regulated transcription of specific genes and gene networks.

Authors:  K R Yamamoto
Journal:  Annu Rev Genet       Date:  1985       Impact factor: 16.830

4.  Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma.

Authors:  P Herbomel; B Bourachot; M Yaniv
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

5.  Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor.

Authors:  S Green; P Chambon
Journal:  Nature       Date:  1987 Jan 1-7       Impact factor: 49.962

6.  Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast.

Authors:  I A Hope; K Struhl
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

7.  A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor.

Authors:  R Brent; M Ptashne
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

8.  Functional domains of the human glucocorticoid receptor.

Authors:  V Giguère; S M Hollenberg; M G Rosenfeld; R M Evans
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

9.  Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor.

Authors:  V Kumar; S Green; A Staub; P Chambon
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

10.  The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors.

Authors:  A Krust; S Green; P Argos; V Kumar; P Walter; J M Bornert; P Chambon
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  34 in total

1.  Proteolytic activity of the purified hormone-binding subunit in the estrogen receptor.

Authors:  A M Molinari; C Abbondanza; I Armetta; N Medici; S Minucci; B Moncharmont; V Nigro; G A Puca
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.

Authors:  L Waltzer; M Perricaudet; A Sergeant; E Manet
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

3.  CDF-1-mediated repression of cell cycle genes targets a specific subset of transactivators.

Authors:  J Zwicker; F C Lucibello; V Jérôme; S Brüsselbach; R Müller
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

4.  The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.

Authors:  J J Voegel; M J Heine; M Tini; V Vivat; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

5.  The product of the adenovirus intermediate gene IX is a transcriptional activator.

Authors:  P Lutz; M Rosa-Calatrava; C Kedinger
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Transcriptional activation by the adenovirus larger E1a product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1a.

Authors:  B Chatton; J L Bocco; M Gaire; C Hauss; B Reimund; J Goetz; C Kedinger
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

7.  The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex.

Authors:  S Obert; R J O'Connor; S Schmid; P Hearing
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  Mutually exclusive interaction of the adenovirus E4-6/7 protein and the retinoblastoma gene product with internal domains of E2F-1 and DP-1.

Authors:  R J O'Connor; P Hearing
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex.

Authors:  L Delva; J N Bastie; C Rochette-Egly; R Kraïba; N Balitrand; G Despouy; P Chambon; C Chomienne
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

10.  Axial (HNF3beta) and retinoic acid receptors are regulators of the zebrafish sonic hedgehog promoter.

Authors:  B E Chang; P Blader; N Fischer; P W Ingham; U Strähle
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.